MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism

Peroxisome proliferator-activated receptor (PPAR)-α/γ dual agonists have been developed to treat metabolic diseases; however, most of them exhibit side effects such as body weight gain and oedema. Therefore, we developed a novel PPARα/γ dual agonist that modulates glucose and lipid metabolism withou...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Sci Rep
मुख्य लेखकों: Kim, Seok-Ho, Hong, Shin Hee, Park, Young-Joon, Sung, Jong-Hyuk, Suh, Wonhee, Lee, Kyeong Won, Jung, Kiwon, Lim, Changjin, Kim, Jin-Hee, Kim, Hyoungsu, Park, Kyong Soo, Park, Sang Gyu
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group UK 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6367362/
https://ncbi.nlm.nih.gov/pubmed/30733541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-38281-0
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन